Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias
Clinical trial NCT03761069 · TERMINATED
Trial details
- NCT number
- NCT03761069
- Sponsor
- PTC Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-29
- Primary completion
- 2021-12-28
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.